Send to

Choose Destination
J Vis Exp. 2018 Oct 25;(140). doi: 10.3791/58285.

Antigenic Liposomes for Generation of Disease-specific Antibodies.

Author information

Janssen R&D.
Department of Microbiology and Immunology, University of North Carolina; UNC Food Allergy Initiative, University of North Carolina.
UNC Food Allergy Initiative, University of North Carolina; Department of Pediatrics, University of North Carolina.
Department of Chemistry, University of Alberta.
Department of Molecular Medicine, Scripps Research Institute.
Department of Chemistry, University of Alberta; Department of Medical Microbiology and Immunology, University of Alberta;


Antibody responses provide critical protective immunity to a wide array of pathogens. There remains a high interest in generating robust antibodies for vaccination as well as understand how pathogenic antibody responses develop in allergies and autoimmune disease. Generating robust antigen-specific antibody responses is not always trivial. In mouse models, it often requires multiple rounds of immunizations with adjuvant that leads to a great deal of variability in the levels of induced antibodies. One example is in mouse models of peanut allergies where more robust and reproducible models that minimize mouse numbers and the use of adjuvant would be beneficial. Presented here is a highly reproducible mouse model of peanut allergy anaphylaxis. This new model relies on two key factors: (1) antigen-specific splenocytes are adoptively transferred from a peanut-sensitized mouse into a naïve recipient mouse, normalizing the number of antigen-specific memory B- and T-cells across a large number of mice; and (2) recipient mice are subsequently boosted with a strong multivalent immunogen in the form of liposomal nanoparticles displaying the major peanut allergen (Ara h 2). The major advantage of this model is its reproducibility, which ultimately lowers the number of animals used in each study, while minimizing the number of animals receiving multiple injections of adjuvant. The modular assembly of these immunogenic liposomes provides relatively facile adaptability to other allergic or autoimmune models that involve pathogenic antibodies.

[Available on 2020-10-25]

Supplemental Content

Full text links

Icon for MyJove Corporation
Loading ...
Support Center